EGFR and lung cancer: Furthermore, Ets-1 inactivation inhibits the transcription of dual specificity phosphatase 6 (DUSP6), a negative regulator of ERK1/2, thereby reactivating ERK1/2 and contributing to the ability of EGFR-mutated lung cancer cells to maintain proliferation and survival signals (please see Figure 3).